PS
CORT icon

Planned Solutions’s Corcept Therapeutics CORT Stock Holding History

Planned Solutions’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,400
Closed -$64.8K – 216
2024
Q3 		$64.8K Buy
+1,400
New +$49.7K 0.03% 266
2024
Q1 		– Sell
-1,400
Closed -$45.5K – 184
2023
Q4 		$45.5K Buy
+1,400
New +$38.4K 0.02% 292
2021
Q1 		– Sell
-2,000
Closed -$52K – 131
2020
Q4 		$52K Buy
2,000
+1,400
+233% +$29.5K 0.04% 188
2020
Q3 		$10K Buy
+600
New +$9.56K 0.01% 256

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Planned Solutions's CORT Position: Q4 2024 in Review

Planned Solutions sold out of Corcept Therapeutics (CORT) in Q4 2024, closing a stake of 1,400 shares — an estimated $64.8K sold.

Planned Solutions first reported a position in CORT in Q3 2020 and held it in 4 quarters. The position peaked at $64.8K in Q3 2024. 367 funds tracked by Wall St. Rank hold CORT as of Q4 2024.

  • Planned Solutions reported no remaining Corcept Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 1,400 Corcept Therapeutics shares in Q4 2024, an estimated $64.8K.
  • Planned Solutions first reported a position in Corcept Therapeutics in Q3 2020 and held it in 4 quarters.
  • Planned Solutions's Corcept Therapeutics position peaked at $64.8K in Q3 2024.
  • 367 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.